1003-3734
2015 Issue 13
..............page:1436
Dalbavancin,a novel glycopeptide antimicrobial agent
BAI Fan;DU Xiao-li;Department of Pharmacy;Peking Union Medical College Hospital;Chinese Academy of Medical Sciences;
BAI Fan;DU Xiao-li;Department of Pharmacy;Peking Union Medical College Hospital;Chinese Academy of Medical Sciences;
..............page:1441-1444+1466
Analysis of market concentration ratio of anti-infective drugs in China
ZHANG Mu-yu;HAN Sheng;GUAN Xiao-dong;YU Xiao-ting;SHI Lu-wen;School of Pharmaceutical Sciences;Peking University;School of Public Health;Peking University;International Research Center of Medicinal Administration;Peking University;
ZHANG Mu-yu;HAN Sheng;GUAN Xiao-dong;YU Xiao-ting;SHI Lu-wen;School of Pharmaceutical Sciences;Peking University;School of Public Health;Peking University;International Research Center of Medicinal Administration;Peking University;
..............page:1445-1450
Production efficiency of sub-industries of Chinese pharmaceutical manufacturing
WANG Xiu-ming;QIU Jia-xue;School of International Pharmaceutical Business;China Pharmaceutical University;
WANG Xiu-ming;QIU Jia-xue;School of International Pharmaceutical Business;China Pharmaceutical University;
..............page:1451-1455
Development of new drugs in China from the market point of view
ZONG Yun-gang;Southern Medicine Economic Research Institute;
ZONG Yun-gang;Southern Medicine Economic Research Institute;
..............page:1456-1459+1513
A few issues in clinical trials of new drugs of traditional Chinese medicine for treating hepatic fibrosis
PEI Xiao-jing;Center for Drug Evaluation;State Food and Drug Administration;
PEI Xiao-jing;Center for Drug Evaluation;State Food and Drug Administration;
..............page:1460-1461
Application of urinary NAG in renal safety evaluation of TCM in an initial human trial
LI Rui;TANG Xu-dong;GAO Hong-yang;ZHAO Ying-pan;HOU Jin-ru;WANG Shu-ge;ZHAO Yang;GAO Rui;Xiyuan Hospital of China Academy of Chinese Medical Sciences;
LI Rui;TANG Xu-dong;GAO Hong-yang;ZHAO Ying-pan;HOU Jin-ru;WANG Shu-ge;ZHAO Yang;GAO Rui;Xiyuan Hospital of China Academy of Chinese Medical Sciences;
..............page:1462-1466
Critical considerations on new drug carcinogenicity evaluation
ZHANG Jing-xuan;WEI Jin-feng;YE Xiang-feng;XIAO Xi-long;WANG Ai-ping;New Drug Safety Evaluation Center in Chinese Academy of Medical Sciences & Peking Union Medical College;
ZHANG Jing-xuan;WEI Jin-feng;YE Xiang-feng;XIAO Xi-long;WANG Ai-ping;New Drug Safety Evaluation Center in Chinese Academy of Medical Sciences & Peking Union Medical College;
..............page:1467-1470
Research progress in the application of mesoporous silica nanoparticles in drug delivery systems
LI Xiao-xi;CHEN Lu;YANG Mei-yan;Institute of Pharmacology and Toxicology;Academy of Military Medical Science;
LI Xiao-xi;CHEN Lu;YANG Mei-yan;Institute of Pharmacology and Toxicology;Academy of Military Medical Science;
..............page:1471-1476
Characterization and selection of recombinant cell line candidates expressing fully-human m Abs against human IgE
ZHANG Yin-chuan;PAN Yong-bing;LIU Meng-meng;GUI Fang;ZHANG Ya-ting;ZHANG Ai-hua;BI Lan;Laboratory of Antibody Drugs;Wuhan Institute of Biological Products Co.;Ltd.;Department of Research and International Cooperation;China National Biotec Group;
ZHANG Yin-chuan;PAN Yong-bing;LIU Meng-meng;GUI Fang;ZHANG Ya-ting;ZHANG Ai-hua;BI Lan;Laboratory of Antibody Drugs;Wuhan Institute of Biological Products Co.;Ltd.;Department of Research and International Cooperation;China National Biotec Group;
..............page:1477-1483
Action mechanisms and application of probiotics in intestinal diseases
ZHOU Jie;ZHU Jun-ping;ZHU Xin-ping;Department of Pathogenic Biology;School of Basic Medical Sciences;Capital Medical University;Research Centre of Microbiome;Capital Medical University;
ZHOU Jie;ZHU Jun-ping;ZHU Xin-ping;Department of Pathogenic Biology;School of Basic Medical Sciences;Capital Medical University;Research Centre of Microbiome;Capital Medical University;
..............page:1484-1487
Research progress of matrix effect in determining blood concentration by LC-MS/MS
FENG Xiao-jie;DU Li-ying;FENG Zhang-ying;WANG Ming-xia;Fourth Hospital of Hebei Medical University;
FENG Xiao-jie;DU Li-ying;FENG Zhang-ying;WANG Ming-xia;Fourth Hospital of Hebei Medical University;
..............page:1488-1492+1497
Gaucher disease and its treatment options
YAN Wei-yang;FENG Wen-hua;Institute of Materia Medica;Chinese Academy of Medical Sciences & Peking Union Medical College;
YAN Wei-yang;FENG Wen-hua;Institute of Materia Medica;Chinese Academy of Medical Sciences & Peking Union Medical College;
..............page:1493-1497
Overview of the treatment of osteoporosis with chemical medicine and traditional Chinese medicine
CHANG Rui-jie;Kunming Baker Norton Pharmaceutical Co.;Ltd.;
CHANG Rui-jie;Kunming Baker Norton Pharmaceutical Co.;Ltd.;
..............page:1498-1503
A double-blind controlled trial of Kaiyuning tablets and fluoxetine for the treatment of mild to moderate depressive disorders
DONG Fang;BO Qi-jing;JIA Hong-xiao;XIAO Fei;YOU Dong-ge;TAN Qing-rong;XU Xiu-feng;DU Bo;HU Xiao-hua;WANG Chuan-yue;Beijing Anding Hospital of Capital Medical University;Beijing Key Laboratory for Mental Disorders;Center of Schizophrenia;Beijing Institute for Brain Disorders;Jianmin Pharmaceutical Groups Co.;Ltd.;Xijing Hospital of the Fourth Military Medical University;First Affiliated Hospital of Kunming Medical University;The Sixth Hospital of Hebei Province;Wuhan Mental Health Center;
DONG Fang;BO Qi-jing;JIA Hong-xiao;XIAO Fei;YOU Dong-ge;TAN Qing-rong;XU Xiu-feng;DU Bo;HU Xiao-hua;WANG Chuan-yue;Beijing Anding Hospital of Capital Medical University;Beijing Key Laboratory for Mental Disorders;Center of Schizophrenia;Beijing Institute for Brain Disorders;Jianmin Pharmaceutical Groups Co.;Ltd.;Xijing Hospital of the Fourth Military Medical University;First Affiliated Hospital of Kunming Medical University;The Sixth Hospital of Hebei Province;Wuhan Mental Health Center;
..............page:1504-1508
Physiologically based pharmacokinetics of pravastatin in healthy volunteers
WANG Hui;ZHU Li-qin;ZHANG Yuan;YANG Jian-wei;Tianjin Fourth Hospital;Tianjin First Central Hospital;Tianjin Medical University;
WANG Hui;ZHU Li-qin;ZHANG Yuan;YANG Jian-wei;Tianjin Fourth Hospital;Tianjin First Central Hospital;Tianjin Medical University;
..............page:1509-1513
Synthesis and antitumor activity of novel 3,4-diaryl squaric acid analogs
GAO Yan;HAN Yan-xing;JIN Jie;LI Zhuo-rong;LIU Zong-ying;Institute of Medicinal Biotechnology;Chinese Academy of Medical Sciences & Peking Union Medical College;
GAO Yan;HAN Yan-xing;JIN Jie;LI Zhuo-rong;LIU Zong-ying;Institute of Medicinal Biotechnology;Chinese Academy of Medical Sciences & Peking Union Medical College;
..............page:1514-1516+1536
Antiallergic effect of tussilagone from Tussilago farfara L.
LI Yan-fang;CHEN Xue-yuan;XIONG Wei-yan;ZHANG Ru-song;YANG Su-bei;Zhejiang Chinese Medical University;Zhejiang Research Institute of Traditional Chinese Medicine Co.;Ltd.;
LI Yan-fang;CHEN Xue-yuan;XIONG Wei-yan;ZHANG Ru-song;YANG Su-bei;Zhejiang Chinese Medical University;Zhejiang Research Institute of Traditional Chinese Medicine Co.;Ltd.;
..............page:1517-1522
Inhibitory effect of SPH0396,a small molecular targeted antitumor agent,on cytochrome P450 isozymes using an in vitro “cocktail”method
ZHANG Le-duo;XIANG Zhi-xiong;WAN Hui-xin;XIA Guang-xin;DMPK Department of Central Research Institute;Central Research Institute;Shanghai Pharmaceuticals Holding Co.;Ltd.;Department of Pharmaceutical Chemistry;Central Research Institute;Shanghai Pharmaceuticals Holding Co.;Ltd.;
ZHANG Le-duo;XIANG Zhi-xiong;WAN Hui-xin;XIA Guang-xin;DMPK Department of Central Research Institute;Central Research Institute;Shanghai Pharmaceuticals Holding Co.;Ltd.;Department of Pharmaceutical Chemistry;Central Research Institute;Shanghai Pharmaceuticals Holding Co.;Ltd.;
..............page:1523-1530
Antidepressive-like effect of daidzein in rats and its mechanism
ZHANG Jia-rui;SUN Da-liang;SHI Juan-juan;ZHAO Jun-ming;Tianjin Anding Hospital;The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine;Institute of Hematology & Blood Diseases Hospital;Chinese Academy of Medical Science;
ZHANG Jia-rui;SUN Da-liang;SHI Juan-juan;ZHAO Jun-ming;Tianjin Anding Hospital;The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine;Institute of Hematology & Blood Diseases Hospital;Chinese Academy of Medical Science;
..............page:1531-1536
Preparation and evaluation of transferrin-modified coumarin-6 liposomes
LU Shan-shan;WANG Dong-yue;GU Wei;PENG Pei;CHEN Jun;YANG Xi-xiong;Laboratory of Pharmaceutics;School of Pharmacy;Nanjing University of Chinese Medicine;Hubei Collaborative Innovation Center of Targeted Antitumor Drug;Jingchu University of Technology;
LU Shan-shan;WANG Dong-yue;GU Wei;PENG Pei;CHEN Jun;YANG Xi-xiong;Laboratory of Pharmaceutics;School of Pharmacy;Nanjing University of Chinese Medicine;Hubei Collaborative Innovation Center of Targeted Antitumor Drug;Jingchu University of Technology;
..............page:1537-1540
..............page:1540+1545
Comparison of the in vitro percutaneous penetration of compound lidocaine cream
LI Jin-hong;HE Ya-jing;HE Ji-xiang;ZHOU Jie;SHEN Teng;Shanxi Xingbang Pharmaceutical Co.;Ltd.;Department of Pharmaceutical Analysis;School of Pharmacy;Shandong University of Traditional Chinese Medicine;Department of Pharmaceutics;School of Pharmacy;Key Laboratory of Smart Drug Delivery;Ministry of Education;Fudan University;
LI Jin-hong;HE Ya-jing;HE Ji-xiang;ZHOU Jie;SHEN Teng;Shanxi Xingbang Pharmaceutical Co.;Ltd.;Department of Pharmaceutical Analysis;School of Pharmacy;Shandong University of Traditional Chinese Medicine;Department of Pharmaceutics;School of Pharmacy;Key Laboratory of Smart Drug Delivery;Ministry of Education;Fudan University;
..............page:1541-1545
Evaluation of modified multi-walled carbon nanotubes with polyethyleneimine and its biocompatibility on PC12 cells
ZHANG Tao;LI Gui-hua;LI Xiao-juan;HAN Bo;ZHAO Wen-bin;School of Pharmacy;Shihezi University;Xinjiang Manasi Jiayuan Hospital;
ZHANG Tao;LI Gui-hua;LI Xiao-juan;HAN Bo;ZHAO Wen-bin;School of Pharmacy;Shihezi University;Xinjiang Manasi Jiayuan Hospital;
..............page:1546-1553
Evaluation of muscular stimulation of reduced glutathione sodium for injection
LI Bei;ZHOU Ying;ZHANG Xing;ZHAO Ying-shu;Hainan Provincial Institute for Food and Drug Control;
LI Bei;ZHOU Ying;ZHANG Xing;ZHAO Ying-shu;Hainan Provincial Institute for Food and Drug Control;
..............page:1554-1556+1560
Effects of patient education in nephrotic syndrome patients taking glucocorticoids
YANG Hui;SHAO Hong;ZHANG Chao;School of Pharmacy;Peking University;Department of Pharmacy;Peking University Third Hospital;
YANG Hui;SHAO Hong;ZHANG Chao;School of Pharmacy;Peking University;Department of Pharmacy;Peking University Third Hospital;
..............page:1557-1560